Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease 2019 Vaccines”

886 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 886 results

Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Not applicableStudy completedNCT05697705
What this trial is testing

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study

Who this might be right for
COVID-19
AstraZeneca 188,814,085
Post-approval studies (Phase 4)Active Not RecruitingNCT07287137
What this trial is testing

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Who this might be right for
COVID -19COVID - 19COVID 19+5 more
Henry M. Jackson Foundation for the Advancement of Military Medicine 54
Not applicableStudy completedNCT05052307
What this trial is testing

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

Who this might be right for
Covid19
Hospital Moinhos de Vento 4,574
Post-approval studies (Phase 4)Study completedNCT05022472
What this trial is testing

Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California

Who this might be right for
Vaccine RefusalCovid19
Britt Skaathun 1,051
Early research (Phase 1)Study completedNCT06032000
What this trial is testing

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Who this might be right for
COVID-19 InfectionCOVID-19 Vaccine Adverse Reaction
Lemonex 20
Not applicableStudy completedNCT04928911
What this trial is testing

Expectations About the COVID-19 Vaccines

Who this might be right for
Vaccine Adverse Reaction
University of Aarhus 1,176
Not applicableStudy completedNCT05515081
What this trial is testing

Antibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB)

Who this might be right for
Vaccine Reaction
IRCCS San Camillo, Venezia, Italy 200
Testing effectiveness (Phase 2)WithdrawnNCT05013983
What this trial is testing

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd.
Testing effectiveness (Phase 2)Ended earlyNCT05016622
What this trial is testing

Booster Dose Trial

Who this might be right for
Cancer
Montefiore Medical Center 106
Testing effectiveness (Phase 2)Ended earlyNCT04788459
What this trial is testing

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Who this might be right for
COVID-19Protection Against COVID-19 and Infections With SARS-CoV- 2COVID-19 Immunisation
Takis 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06919796
What this trial is testing

MRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

Who this might be right for
Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy VolunteersSARS CoV-2
PharmaJet, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05148091
What this trial is testing

The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

Who this might be right for
COVID-19
Sinocelltech Ltd. 478
Large-scale testing (Phase 3)Study completedNCT05542862
What this trial is testing

Booster Study of SpikoGen COVID-19 Vaccine

Who this might be right for
COVID-19
Vaxine Pty Ltd 81
Testing effectiveness (Phase 2)Study completedNCT05727215
What this trial is testing

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

Who this might be right for
COVID-19
PT Bio Farma 150
Not applicableUnknownNCT05175989
What this trial is testing

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Who this might be right for
COVID-19 Vaccine
Rabin Medical Center 150
Post-approval studies (Phase 4)Study completedNCT06065176
What this trial is testing

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Who this might be right for
COVID-19Vaccine-Preventable DiseasesSARS CoV 2 Infection+2 more
Sarang K. Yoon, DO, MOH 1,188
Post-approval studies (Phase 4)Study completedNCT06189040
What this trial is testing

Immunogenicity After COVID-19 Vaccines in Adapted Schedules

Who this might be right for
Coronavirus Disease 2019COVID-19
Universiteit Antwerpen 580
Testing effectiveness (Phase 2)Study completedNCT04889209
What this trial is testing

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 867
Early research (Phase 1)Active Not RecruitingNCT06950177
What this trial is testing

Pancoronavirus Vaccine Study in Healthy Adults

Who this might be right for
COVID-19 Respiratory InfectionSARS CoV 2 InfectionCOVID-19 Vaccine
Duke University 51
Next Page